enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Costco’s Kirkland vs. Walmart’s Great Value Brand: Which ...

   www.aol.com/costco-kirkland-vs-walmart-great...

   If you compare a 30-pack of 2-ply toilet paper, the Great Value version is $19.98, while Costco offers a Kirkland version for $23.99. Walmart also offers a greater selection of sizes, whereas ...

3. List of Walmart brands - Wikipedia

   en.wikipedia.org/wiki/List_of_Walmart_brands

   Like other Walmart store brands, its design and packaging was relaunched in 2010. Parent's Choice is manufactured by Wyeth, a pharmaceutical company that is a subsidiary of Pfizer . [ citation needed ] On October 15, 2009, representatives of Pfizer signed the final acquisition papers, making Wyeth a wholly owned subsidiary of that company, thus ...

4. How Walmart's Sam's Club is trying to take on Costco's Kirkland

   www.aol.com/news/walmarts-sam-club-trying-costco...

   Walmart's Sam's Club battles Costco's Kirkland as private labels drive hot growth for the likes of Trader Joe's, Aldi and Lidl.

5. Esketamine - Wikipedia

   en.wikipedia.org/wiki/Esketamine

   Esketamine, sold under the brand names Spravato (for depression) and Ketanest (for anesthesia) among others, [10] [12] is the S(+) enantiomer of ketamine. [5] [13] It is a dissociative hallucinogen drug used as a general anesthetic and as an antidepressant for treatment of depression.

6. Levmetamfetamine - Wikipedia

   en.wikipedia.org/wiki/Levmetamfetamine

   Levmetamfetamine, also known as l-desoxyephedrine or levomethamphetamine, and commonly sold under the brand name Vicks VapoInhaler among others, is an optical isomer of methamphetamine primarily used as a topical nasal decongestant. [2] It is used to treat nasal congestion from allergies and the common cold. [7]

7. FDA-approved nasal spray for severe depression can lead to ...

   www.aol.com/fda-approved-nasal-spray-severe...

   The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.